Clinical trials recruiting for Acute Treatment of Migraine
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Rimegepant | 1 |
| Rimegepant (PF-07899801) | 1 |
| Rimegepant 75 mg ODT | 1 |
| Zavegepant | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| North Carolina | 3 |
| Texas | 3 |
| California | 2 |
| District of Columbia | 2 |
| Florida | 2 |
| Georgia | 2 |
| Massachusetts | 2 |
| Michigan | 2 |
| Nebraska | 2 |
| New York | 2 |
| Oklahoma | 2 |
| Utah | 2 |
Top cities
Self-screener
Recruiting trials
- A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
- A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
- A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Related conditions
Trials recruiting for Acute Treatment of Migraine often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Acute Treatment of Migraine trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.